Trial Profile
A Phase I, Pharmacokinetic Trial, in Healthy Asian and Caucasian Volunteers for Investigating the Pharmacokinetic Profiles of Eurartesim (40 mg Dihydroartemisinin (DHA)/320 mg Piperaquine (PQ) Phosphate.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary)
- Indications Falciparum malaria
- Focus Pharmacokinetics
- Sponsors sigma-tau SpA
- 30 Jun 2016 New trial record